Variant report
Variant | esv2763960 |
---|---|
Chromosome Location | chr6:162542479-163036223 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:1707)
- CpG islands (count:734)
- Chromatin interactive region (count:37)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr6:162857639-162857816 | HepG2 | liver: | n/a | n/a |
2 | ARID3A | chr6:162910482-162910786 | HepG2 | liver: | n/a | n/a |
3 | ARID3A | chr6:162794306-162794665 | HepG2 | liver: | n/a | n/a |
4 | ARID3A | chr6:162671087-162671724 | HepG2 | liver: | n/a | n/a |
5 | ATF1 | chr6:162782228-162782581 | K562 | blood: | n/a | n/a |
6 | ATF1 | chr6:162812215-162812339 | K562 | blood: | n/a | n/a |
7 | ATF1 | chr6:162784797-162785113 | K562 | blood: | n/a | n/a |
8 | ATF1 | chr6:162812647-162812847 | K562 | blood: | n/a | n/a |
9 | ATF3 | chr6:162784742-162785052 | K562 | blood: | n/a | n/a |
10 | BACH1 | chr6:162975725-162976098 | K562 | blood: | n/a | n/a |
11 | BHLHE40 | chr6:162599602-162599788 | HepG2 | liver: | n/a | chr6:162599639-162599660 chr6:162599645-162599654 chr6:162599645-162599654 chr6:162599643-162599656 chr6:162599644-162599653 |
12 | BHLHE40 | chr6:162899266-162899534 | GM12878 | blood: | n/a | n/a |
13 | BHLHE40 | chr6:162578294-162578454 | GM12878 | blood: | n/a | n/a |
14 | BHLHE40 | chr6:162576834-162576960 | GM12878 | blood: | n/a | n/a |
15 | BRCA1 | chr6:162658617-162658742 | Hela-S3 | cervix: | n/a | n/a |
16 | BRCA1 | chr6:162871740-162871751 | H1-hESC | embryonic stem cell: | n/a | n/a |
17 | CBX3 | chr6:162784775-162785143 | K562 | blood: | n/a | n/a |
18 | CBX3 | chr6:162785538-162785848 | K562 | blood: | n/a | n/a |
19 | CCNT2 | chr6:163001825-163002025 | K562 | blood: | n/a | n/a |
20 | CEBPB | chr6:162671554-162671904 | HepG2 | liver: | n/a | n/a |
21 | CEBPB | chr6:162871443-162871750 | MCF-7 | breast: | n/a | chr6:162871605-162871616 |
22 | CEBPB | chr6:162871405-162871712 | H1-hESC | embryonic stem cell: | n/a | chr6:162871605-162871616 |
23 | CEBPB | chr6:162599813-162600021 | Hela-S3 | cervix: | n/a | chr6:162599866-162599877 |
24 | CEBPB | chr6:162910493-162910789 | HepG2 | liver: | n/a | n/a |
25 | CEBPB | chr6:162876249-162876534 | IMR90 | lung: | n/a | n/a |
26 | CEBPB | chr6:162766353-162766628 | IMR90 | lung: | n/a | chr6:162766482-162766491 chr6:162766482-162766491 chr6:162766481-162766492 chr6:162766482-162766491 chr6:162766480-162766491 chr6:162766482-162766491 chr6:162766480-162766493 |
27 | CEBPB | chr6:162784873-162785124 | H1-hESC | embryonic stem cell: | n/a | chr6:162785029-162785040 |
28 | CEBPB | chr6:162779076-162779247 | A549 | lung: | n/a | chr6:162779118-162779129 |
29 | CEBPB | chr6:162857299-162857541 | HepG2 | liver: | n/a | chr6:162857420-162857431 |
30 | CEBPB | chr6:162559772-162560081 | HepG2 | liver: | n/a | chr6:162559914-162559925 |
31 | CEBPB | chr6:162779025-162779284 | HepG2 | liver: | n/a | chr6:162779118-162779129 |
32 | CEBPB | chr6:162871496-162871684 | HepG2 | liver: | n/a | chr6:162871605-162871616 |
33 | CEBPB | chr6:162784761-162785142 | K562 | blood: | n/a | chr6:162785029-162785040 |
34 | CEBPB | chr6:163036076-163036363 | H1-hESC | embryonic stem cell: | n/a | chr6:163036237-163036246 chr6:163036118-163036129 chr6:163036237-163036246 chr6:163036118-163036129 chr6:163036235-163036248 chr6:163036235-163036248 chr6:163036237-163036246 chr6:163036116-163036129 chr6:163036236-163036247 |
35 | CEBPB | chr6:162671584-162671889 | IMR90 | lung: | n/a | n/a |
36 | CEBPB | chr6:162568836-162569161 | K562 | blood: | n/a | chr6:162568989-162568998 chr6:162568989-162568998 chr6:162568989-162568998 chr6:162568987-162569000 chr6:162568988-162568999 chr6:162568987-162569000 |
37 | CEBPB | chr6:162871429-162871791 | HepG2 | liver: | n/a | chr6:162871605-162871616 |
38 | CEBPB | chr6:162868765-162868950 | HepG2 | liver: | n/a | chr6:162868884-162868895 |
39 | CEBPB | chr6:162857280-162857594 | HepG2 | liver: | n/a | chr6:162857420-162857431 |
40 | CEBPB | chr6:162559819-162560075 | A549 | lung: | n/a | chr6:162559914-162559925 |
41 | CEBPB | chr6:162656289-162656489 | A549 | lung: | n/a | n/a |
42 | CEBPB | chr6:162857291-162857590 | HepG2 | liver: | n/a | chr6:162857420-162857431 |
43 | CEBPB | chr6:162961979-162962215 | HepG2 | liver: | n/a | chr6:162962080-162962091 |
44 | CEBPB | chr6:162766332-162766577 | H1-hESC | embryonic stem cell: | n/a | chr6:162766482-162766491 chr6:162766482-162766491 chr6:162766481-162766492 chr6:162766482-162766491 chr6:162766480-162766491 chr6:162766482-162766491 chr6:162766480-162766493 |
45 | CEBPB | chr6:163036084-163036403 | A549 | lung: | n/a | chr6:163036237-163036246 chr6:163036118-163036129 chr6:163036237-163036246 chr6:163036118-163036129 chr6:163036235-163036248 chr6:163036235-163036248 chr6:163036237-163036246 chr6:163036116-163036129 chr6:163036236-163036247 |
46 | CEBPB | chr6:162671564-162671902 | A549 | lung: | n/a | n/a |
47 | CEBPB | chr6:162896813-162896974 | HepG2 | liver: | n/a | chr6:162896839-162896850 |
48 | CEBPB | chr6:162910460-162910714 | HepG2 | liver: | n/a | n/a |
49 | CEBPB | chr6:162672448-162672478 | HepG2 | liver: | n/a | n/a |
50 | CEBPB | chr6:162766327-162766640 | HepG2 | liver: | n/a | chr6:162766482-162766491 chr6:162766482-162766491 chr6:162766481-162766492 chr6:162766482-162766491 chr6:162766480-162766491 chr6:162766482-162766491 chr6:162766480-162766493 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:162964378-162964428 | NHDF-neo | bronchial: | n/a |
2 | chr6:162865171-162865221 | HPAEpiC | pulmonary alveolar: | n/a |
3 | chr6:162964378-162964428 | NHDF-neo | bronchial: | n/a |
4 | chr6:162865171-162865221 | HPAEpiC | pulmonary alveolar: | n/a |
5 | chr6:162864586-162864636 | NB4 | blood: | n/a |
6 | chr6:162683857-162683907 | GM12891 | blood: | n/a |
7 | chr6:162864586-162864636 | K562 | blood: | n/a |
8 | chr6:162683881-162683931 | SK-N-MC | brain: | n/a |
9 | chr6:162865258-162865308 | HRCEpiC | kidney: | n/a |
10 | chr6:162683961-162684011 | GM12891 | blood: | n/a |
11 | chr6:162831837-162831887 | NHBE | bronchial: | n/a |
12 | chr6:162964378-162964428 | AG04450 | lung: | fetal |
13 | chr6:162683881-162683931 | LNCaP | prostate: | n/a |
14 | chr6:162865171-162865221 | NH-A | brain: | n/a |
15 | chr6:162684526-162684576 | Jurkat | blood: | n/a |
16 | chr6:162865171-162865221 | HCT-116 | colon: | n/a |
17 | chr6:162964378-162964428 | HEEpiC | esophagus: | n/a |
18 | chr6:162865171-162865221 | AG04450 | lung: | fetal |
19 | chr6:162683961-162684011 | HUVEC | blood vessel: | n/a |
20 | chr6:162864586-162864636 | CMK | blood: | n/a |
21 | chr6:162831837-162831887 | GM12892 | blood: | n/a |
22 | chr6:162964378-162964428 | AG10803 | skin: | n/a |
23 | chr6:163024624-163024674 | SK-N-SH_RA | brain: | n/a |
24 | chr6:162683961-162684011 | NB4 | blood: | n/a |
25 | chr6:162865258-162865308 | IMR90 | lung: | fetal |
26 | chr6:162683857-162683907 | Hela-S3 | cervix: | n/a |
27 | chr6:162684526-162684576 | AG09319 | gingival: | n/a |
28 | chr6:162865258-162865308 | MCF10A-Er-Src | breast: | n/a |
29 | chr6:162964378-162964428 | ovcar-3 | ovarian: | n/a |
30 | chr6:162683857-162683907 | K562 | blood: | n/a |
31 | chr6:162684441-162684491 | PFSK-1 | brain: | n/a |
32 | chr6:162684441-162684491 | HRCEpiC | kidney: | n/a |
33 | chr6:162863505-162863555 | MCF-7 | breast: | n/a |
34 | chr6:162683961-162684011 | Jurkat | blood: | n/a |
35 | chr6:162865258-162865308 | RPTEC | kidney: | n/a |
36 | chr6:162864586-162864636 | NHDF-neo | bronchial: | n/a |
37 | chr6:162863505-162863555 | NHBE | bronchial: | n/a |
38 | chr6:162684441-162684491 | BE2_C | brain: | n/a |
39 | chr6:162683881-162683931 | PFSK-1 | brain: | n/a |
40 | chr6:163024624-163024674 | MCF10A-Er-Src | breast: | n/a |
41 | chr6:162684526-162684576 | HEK293 | kidney: | embryo |
42 | chr6:162683961-162684011 | ovcar-3 | ovarian: | n/a |
43 | chr6:162684526-162684576 | A549 | lung: | n/a |
44 | chr6:162684441-162684491 | HRPEpiC | eye: | n/a |
45 | chr6:162683881-162683931 | ovcar-3 | ovarian: | n/a |
46 | chr6:162684441-162684491 | ProgFib | skin: | n/a |
47 | chr6:162864586-162864636 | ProgFib | skin: | n/a |
48 | chr6:162684441-162684491 | MCF10A-Er-Src | breast: | n/a |
49 | chr6:162865258-162865308 | BJ | skin: | n/a |
50 | chr6:162684526-162684576 | HRE | kidney: | n/a |
(count:37 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:162763017..162765353-chr6:162767098..162769301,2 | K562 | blood: | |
2 | chr6:162666890..162668464-chr6:162670216..162671922,2 | K562 | blood: | |
3 | chr6:162258059..162258779-chr6:162552660..162553528,2 | MCF-7 | breast: | |
4 | chr6:162799485..162803733-chr6:162804296..162807777,5 | K562 | blood: | |
5 | chr6:162553757..162556831-chr6:162558713..162560436,3 | K562 | blood: | |
6 | chr6:162661286..162663139-chr6:162673530..162675376,2 | K562 | blood: | |
7 | chr6:162721411..162723925-chr6:162726328..162729326,2 | K562 | blood: | |
8 | chr6:162661286..162663139-chr6:162673530..162675376,2 | K562 | blood: | |
9 | chr6:162613600..162615384-chr6:162617227..162618872,2 | K562 | blood: | |
10 | chr6:162620407..162622935-chr6:162623040..162625617,2 | K562 | blood: | |
11 | chr6:162960178..162962006-chr6:162962880..162965078,2 | K562 | blood: | |
12 | chr6:162620407..162622935-chr6:162623040..162625617,2 | K562 | blood: | |
13 | chr6:163002877..163005708-chr6:163021910..163024946,3 | K562 | blood: | |
14 | chr6:163002877..163005708-chr6:163021910..163024946,3 | K562 | blood: | |
15 | chr6:162902802..162905070-chr6:162905406..162907332,2 | K562 | blood: | |
16 | chr6:162671180..162673472-chr6:162808694..162811227,2 | K562 | blood: | |
17 | chr6:162643217..162645721-chr6:162646719..162648950,2 | K562 | blood: | |
18 | chr6:162863367..162864320-chr6:163157771..163158572,4 | MCF-7 | breast: | |
19 | chr6:162960178..162962006-chr6:162962880..162965078,2 | K562 | blood: | |
20 | chr6:162768506..162770213-chr6:162786241..162788330,2 | K562 | blood: | |
21 | chr6:162863816..162864618-chr6:163271757..163272511,2 | MCF-7 | breast: | |
22 | chr6:162574333..162576032-chr6:162578404..162580150,2 | K562 | blood: | |
23 | chr6:162721411..162723925-chr6:162726328..162729326,2 | K562 | blood: | |
24 | chr6:162902802..162905070-chr6:162905406..162907332,2 | K562 | blood: | |
25 | chr6:162666890..162668464-chr6:162670216..162671922,2 | K562 | blood: | |
26 | chr6:162552000..162556573-chr6:162556763..162561114,5 | K562 | blood: | |
27 | chr6:162553757..162556831-chr6:162558713..162560436,3 | K562 | blood: | |
28 | chr6:162768506..162770213-chr6:162786241..162788330,2 | K562 | blood: | |
29 | chr6:162671180..162673472-chr6:162808694..162811227,2 | K562 | blood: | |
30 | chr6:162763017..162765353-chr6:162767098..162769301,2 | K562 | blood: | |
31 | chr6:162820265..162823089-chr6:162827852..162829559,2 | K562 | blood: | |
32 | chr6:162613600..162615384-chr6:162617227..162618872,2 | K562 | blood: | |
33 | chr6:162574333..162576032-chr6:162578404..162580150,2 | K562 | blood: | |
34 | chr6:162820265..162823089-chr6:162827852..162829559,2 | K562 | blood: | |
35 | chr6:162799485..162803733-chr6:162804296..162807777,5 | K562 | blood: | |
36 | chr6:162643217..162645721-chr6:162646719..162648950,2 | K562 | blood: | |
37 | chr6:162552000..162556573-chr6:162556763..162561114,5 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
KRT8P44 | TF binding region |
KRT8P44 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9355981 | chr6:162542479-162542480 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs553595894 | chr6:162542491-162542492 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs573436178 | chr6:162542637-162542638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs545621976 | chr6:162542641-162542642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs565552479 | chr6:162542666-162542667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs576025711 | chr6:162542677-162542678 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs536485402 | chr6:162542703-162542704 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs551854583 | chr6:162542738-162542739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs543837857 | chr6:162542742-162542743 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs560983919 | chr6:162542782-162542783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs183529308 | chr6:162542796-162542797 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs187117589 | chr6:162542807-162542808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs559816975 | chr6:162542808-162542809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs192180866 | chr6:162542828-162542829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs34493917 | chr6:162542829-162542830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs141652811 | chr6:162542838-162542839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs150499361 | chr6:162542851-162542852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs538169641 | chr6:162542877-162542878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs111343379 | chr6:162542891-162542892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs116604799 | chr6:162542899-162542900 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs567694193 | chr6:162542917-162542918 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs368305995 | chr6:162542966-162542967 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs1954921 | chr6:162543008-162543009 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs139518744 | chr6:162543083-162543084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs78838724 | chr6:162543205-162543206 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
26 | rs118022863 | chr6:162543304-162543305 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
27 | rs6940203 | chr6:162543349-162543350 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs535598491 | chr6:162543415-162543416 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs80114747 | chr6:162543436-162543437 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs544928316 | chr6:162543444-162543445 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs182604276 | chr6:162543473-162543474 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs574327252 | chr6:162543539-162543540 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs12195520 | chr6:162543542-162543543 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs539862439 | chr6:162543580-162543581 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs559782373 | chr6:162543621-162543622 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs532109913 | chr6:162543721-162543722 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs551932922 | chr6:162543739-162543740 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs377242926 | chr6:162543748-162543749 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs112270112 | chr6:162543749-162543750 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs71544924 | chr6:162543791-162543792 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs562390663 | chr6:162543820-162543821 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs539702491 | chr6:162543836-162543837 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs531499202 | chr6:162543893-162543894 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs187685778 | chr6:162543897-162543898 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs191862018 | chr6:162543925-162543926 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs182484445 | chr6:162543949-162543950 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs547034806 | chr6:162543951-162543952 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs566958422 | chr6:162543953-162543954 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs539180473 | chr6:162543981-162543982 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs187488006 | chr6:162543994-162543995 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 22241247 | CNVD |
Breast cancer | 16397240 | CNVD |
Atherosclerosis | 21956041 | CNVD |
Maculopathy | 20981449 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Astrocytoma | 16205629 | CNVD |
Parkinson disease | 17160897 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 22522925 | CNVD |
Schizophrenia | 20838587 | CNVD |
Early-onset parkinson disease | 21993715 | CNVD |
Glioblastoma | 18772890 | CNVD |
Pancreatic cancer | 20981101 | CNVD |
Autism | 21360662 | CNVD |
Melanoma | 20877625 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Intellectual disability | 22102821 | CNVD |
Parkinson disease | 0 | CNVD |
Cancer | 20164919 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Parkinson disease | 21829596 | CNVD |
Schizophrenia | 23813976 | CNVD |
Gastric cancer | 22315472 | CNVD |
Autism | 19404257 | CNVD |
Schizophrenia | 20967226 | CNVD |
Schizophrenia | 21346763 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
Attention deficit hyperactivity disorder | 19546859 | CNVD |
Autism | 22495309 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Ovarian cancer | 22355333 | CNVD |
Schizophrenia | 19805367 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:162536400-162543200 | Weak transcription | Aorta | Aorta |
2 | chr6:162540200-162543400 | Weak transcription | Brain Substantia Nigra | brain |
3 | chr6:162540800-162543200 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
4 | chr6:162540800-162543200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr6:162540800-162543200 | Weak transcription | Psoas Muscle | Psoas |
6 | chr6:162540800-162545800 | Weak transcription | Right Atrium | heart |
7 | chr6:162541000-162545000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr6:162541200-162545200 | Weak transcription | HSMM | muscle |
9 | chr6:162543200-162543400 | ZNF genes & repeats | Aorta | Aorta |
10 | chr6:162543200-162543400 | Enhancers | Psoas Muscle | Psoas |
11 | chr6:162543200-162543600 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
12 | chr6:162543200-162544000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
13 | chr6:162543400-162543800 | Enhancers | Brain Substantia Nigra | brain |
14 | chr6:162543800-162545200 | Weak transcription | Brain Substantia Nigra | brain |
15 | chr6:162545000-162545400 | Enhancers | Fetal Lung | lung |
16 | chr6:162545000-162546000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
17 | chr6:162545000-162546200 | Enhancers | NH-A | brain |
18 | chr6:162545200-162545600 | Enhancers | Brain Substantia Nigra | brain |
19 | chr6:162545200-162546000 | Enhancers | HSMM | muscle |
20 | chr6:162545800-162546200 | Enhancers | Right Atrium | heart |
21 | chr6:162556600-162556800 | Enhancers | Psoas Muscle | Psoas |
22 | chr6:162557400-162557800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
23 | chr6:162560600-162561000 | Enhancers | Monocytes-CD14+_RO01746 | blood |
24 | chr6:162560600-162562200 | Enhancers | Primary monocytes fromperipheralblood | blood |
25 | chr6:162560600-162572000 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
26 | chr6:162561000-162561800 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
27 | chr6:162561800-162562000 | Enhancers | Monocytes-CD14+_RO01746 | blood |
28 | chr6:162562800-162563400 | Enhancers | Skeletal Muscle Female | skeletal muscle |
29 | chr6:162563200-162563400 | ZNF genes & repeats | Aorta | Aorta |
30 | chr6:162563200-162563400 | Enhancers | Psoas Muscle | Psoas |
31 | chr6:162563400-162571400 | Weak transcription | Psoas Muscle | Psoas |
32 | chr6:162563400-162574200 | Weak transcription | Aorta | Aorta |
33 | chr6:162570600-162571000 | Enhancers | H1 Cell Line | embryonic stem cell |
34 | chr6:162570600-162571000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
35 | chr6:162570600-162571200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
36 | chr6:162570600-162571200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
37 | chr6:162570600-162571400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
38 | chr6:162570600-162571400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
39 | chr6:162570600-162571400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
40 | chr6:162570600-162571800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
41 | chr6:162570800-162573600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
42 | chr6:162571000-162571600 | Enhancers | Monocytes-CD14+_RO01746 | blood |
43 | chr6:162571200-162573200 | Enhancers | Primary monocytes fromperipheralblood | blood |
44 | chr6:162571400-162571600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
45 | chr6:162571400-162571600 | Enhancers | Psoas Muscle | Psoas |
46 | chr6:162571600-162572000 | Weak transcription | Psoas Muscle | Psoas |
47 | chr6:162571600-162572000 | Enhancers | NH-A | brain |
48 | chr6:162571600-162572600 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
49 | chr6:162571600-162572800 | Enhancers | HSMMtube | muscle |
50 | chr6:162571600-162573200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |